skbr3 cells (ATCC)
ATCC is a verified supplier 
ATCC manufactures this product 
99
Structured Review
ATCC
skbr3 cells
Skbr3 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 6531 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sk+br/SK-BR-3/pm42320630-134-0-2
Average 99 stars, based on 6531 article reviews
Skbr3 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 6531 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sk+br/SK-BR-3/pm42320630-134-0-2
Average 99 stars, based on 6531 article reviews
skbr3 cells - by Bioz Stars,
2026-09
99/100 stars
Images
Related Articles
RNA sequencing:Article Title: Methods for in situ transcriptomics and proteomics Article Snippet: .. Based on RNAseq data reported on The Human Protein Atlas, the Expressing:Article Title: Methods for in situ transcriptomics and proteomics Article Snippet: .. Based on RNAseq data reported on The Human Protein Atlas, the other:Article Title: Antibody, linkers, payload, conjugates and applications thereof Article Snippet: MS: Thermo Fisher Q Exactive Plus, Water2795-Quattro micro triple quadrupole mass spectrometer HPLC: Waters 2695, Agilent 1100, Agilent 1200 Semi-preparative HPLC: Lisure HP plus 50D Flow Cytometry: CytoFLEX S HIC-HPLC: Butyl-HIC; mobile phase A: 25 mM PB, 2M (NH4)2SO4, pH 7.0; mobile phase B: 25 mM PB, pH 7.0; flow rate: 0.8 ml/min; acquisition time: 25 min; injection amount: 20 μg; column temperature: 25° C.; detection wavelength: 280 nm; sample chamber temperature: 8° C. SEC-HPLC: column: TSK-gel G3000 SWXL, TOSOH 7.8 mm ID×300 mm, 5 μm; mobile phase: 0.2 M KH2PO4, 0.25 M KCl, pH 6.2; flow rate: 0.5 ml/min; acquisition time: 30 min; injection volume: 50 μl; column temperature: 25° C.; detection wavelength; 280 nm; sample tray temperature: 8° C. CHO was obtained from Thermo Fisher Scientific; pcDNA 3.3 was obtained from Life Technology; HEK293F was obtained from Prejin; PEIMAX transfection reagent was obtained from Polyscience; MabSelect Sure ProA was obtained from GE; Capto S ImpAct was obtained from GE; Rink-amide-MBHA-resin and dichloro resin were obtained from Nankai synthesis; HCC1954 was obtained from Activity Assay:Article Title: De novo masking domains that gate TNF-family ligand assembly and activity Article Snippet: Data were analyzed in GraphPad Prism, and EC50 values were obtained by nonlinear regression using a four-parameter logistic model. .. Cytotoxic activity of ADCs was evaluated using Article Title: De novo masking domains that gate TNF-family ligand assembly and activity Article Snippet: .. Cell binding activity of antibodies and ADCs was evaluated using Cell Culture:Article Title: A novel synthetic melanin as a potential anticancer agent that induces apoptosis and cyclin D downregulation through distinct pathways. Article Snippet: .. 692 693 Cell line and cell culture 694 Human cancer cell lines, HeLa (uterine cervix), HepG2 (liver), Jurkat (T lymphocyte), Article Title: HSP90AA1-VDAC1 interaction contributes to breast cancer progression and doxorubicin resistance through PI3K/AKT signaling. Article Snippet: .. Cell culture 124 The normal mammary epithelial cell line MCF-10A and BC cell 125 lines MCF-7, BT474, MDA-MB-231, and Multiple Displacement Amplification:Article Title: HSP90AA1-VDAC1 interaction contributes to breast cancer progression and doxorubicin resistance through PI3K/AKT signaling. Article Snippet: .. Cell culture 124 The normal mammary epithelial cell line MCF-10A and BC cell 125 lines MCF-7, BT474, MDA-MB-231, and Article Title: HSP90AA1–VDAC1 interaction contributes to breast cancer progression and doxorubicin resistance through PI3K/AKT signaling Article Snippet: .. The normal mammary epithelial cell line MCF-10A and BC cell lines MCF-7, BT474, MDA-MB-231, and Binding Assay:Article Title: De novo masking domains that gate TNF-family ligand assembly and activity Article Snippet: .. Cell binding activity of antibodies and ADCs was evaluated using |